A detailed history of Public Sector Pension Investment Board transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Public Sector Pension Investment Board holds 4,341 shares of REGN stock, worth $3.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,341
Previous 3,841 13.02%
Holding current value
$3.31 Million
Previous $4.04 Million 13.03%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $512,044 - $600,880
500 Added 13.02%
4,341 $4.56 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $1.48 Million - $1.8 Million
1,679 Added 77.66%
3,841 $4.04 Million
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $254,558 - $280,124
-282 Reduced 11.54%
2,162 $2.08 Million
Q4 2023

Feb 14, 2024

SELL
$775.18 - $881.7 $6.97 Million - $7.93 Million
-8,990 Reduced 78.63%
2,444 $2.15 Million
Q3 2023

Nov 22, 2023

BUY
$692.45 - $844.37 $763,772 - $931,340
1,103 Added 10.68%
11,434 $9.41 Million
Q2 2023

Aug 14, 2023

SELL
$700.03 - $830.35 $1.05 Million - $1.24 Million
-1,497 Reduced 12.66%
10,331 $7.42 Million
Q1 2023

May 12, 2023

SELL
$680.49 - $826.97 $1.02 Million - $1.24 Million
-1,504 Reduced 11.28%
11,828 $9.72 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $1.3 Million - $1.41 Million
1,842 Added 16.03%
13,332 $9.62 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $630,793 - $796,027
1,099 Added 10.58%
11,490 $7.92 Million
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $2.51 Million - $3.39 Million
-4,582 Reduced 30.6%
10,391 $6.14 Million
Q1 2022

May 13, 2022

SELL
$595.12 - $698.43 $1.59 Million - $1.86 Million
-2,670 Reduced 15.13%
14,973 $10.5 Million
Q4 2021

Feb 14, 2022

SELL
$543.48 - $670.97 $43,478 - $53,677
-80 Reduced 0.45%
17,643 $11.1 Million
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $751,979 - $892,057
1,310 Added 7.98%
17,723 $10.7 Million
Q2 2021

Aug 13, 2021

BUY
$472.8 - $558.54 $3.05 Million - $3.61 Million
6,460 Added 64.91%
16,413 $9.17 Million
Q1 2021

May 14, 2021

BUY
$446.73 - $548.2 $763,908 - $937,422
1,710 Added 20.74%
9,953 $4.71 Million
Q4 2020

Feb 12, 2021

SELL
$478.3 - $607.98 $2.1 Million - $2.67 Million
-4,390 Reduced 34.75%
8,243 $3.98 Million
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $1.56 Million - $1.89 Million
2,870 Added 29.4%
12,633 $7.07 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $887,976 - $1.16 Million
1,800 Added 22.6%
9,763 $6.09 Million
Q1 2020

May 14, 2020

SELL
$336.18 - $494.43 $10.8 Million - $15.9 Million
-32,150 Reduced 80.15%
7,963 $3.89 Million
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $362,948 - $498,499
1,324 Added 3.41%
40,113 $15.1 Million
Q3 2019

Nov 14, 2019

BUY
$273.46 - $318.39 $1.43 Million - $1.67 Million
5,241 Added 15.62%
38,789 $10.8 Million
Q2 2019

Aug 14, 2019

BUY
$299.6 - $414.82 $1.11 Million - $1.53 Million
3,700 Added 12.4%
33,548 $10.5 Million
Q1 2019

May 14, 2019

BUY
$372.08 - $439.57 $9.62 Million - $11.4 Million
25,866 Added 649.57%
29,848 $12.3 Million
Q4 2018

Feb 14, 2019

BUY
$335.82 - $403.04 $100,746 - $120,912
300 Added 8.15%
3,982 $1.49 Million
Q3 2018

Nov 14, 2018

SELL
$351.14 - $408.51 $245,798 - $285,957
-700 Reduced 15.97%
3,682 $1.49 Million
Q1 2018

May 10, 2018

BUY
$315.82 - $393.78 $63,164 - $78,756
200 Added 4.78%
4,382 $1.51 Million
Q4 2017

Feb 02, 2018

BUY
$358.63 - $469.95 $71,726 - $93,990
200 Added 5.02%
4,182 $1.57 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $1.72 Million - $2.01 Million
3,982
3,982 $0

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Public Sector Pension Investment Board Portfolio

Follow Public Sector Pension Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.